Calcinosis cutis: part I. Diagnostic pathway

N Reiter, L El-Shabrawi, B Leinweber… - Journal of the American …, 2011 - Elsevier
Calcinosis cutis is characterized by the deposition of insoluble calcium salts in the skin and
subcutaneous tissue. The syndrome is separated into five subtypes: dystrophic calcification …

[HTML][HTML] The role of senescence in cellular plasticity: Lessons from regeneration and development and implications for age-related diseases

NAR Ring, K Valdivieso, J Grillari, H Redl… - Developmental cell, 2022 - cell.com
Senescence is a cellular state which involves cell cycle arrest and a proinflammatory
phenotype, and it has traditionally been associated with cellular and organismal aging …

Adipocyte dedifferentiation in health and diseases

T Song, S Kuang - Clinical Science, 2019 - portlandpress.com
Adipose tissues collectively as an endocrine organ and energy storage are crucial for
systemic metabolic homeostasis. The major cell type in the adipose tissue, the adipocytes or …

Calcinosis cutis: part II. Treatment options

N Reiter, L El-Shabrawi, B Leinweber… - Journal of the American …, 2011 - Elsevier
Because calcinosis cutis is a rare syndrome, there is a notable lack of controlled clinical
trials on its treatment. The efficacy of calcinosis treatment has only been reported in single …

[HTML][HTML] Development of selective inhibitors and substrate of matrix metalloproteinase-12

L Devel, V Rogakos, A David, A Makaritis… - Journal of Biological …, 2006 - ASBMB
Four phosphinic peptide libraries with compounds having the general formula p-Br-Ph-(PO 2-
CH 2)-Xaa′-Yaa′-Zaa′-NH 2 have been prepared and screened against 10 matrix …

Association between tendon ruptures and use of fluoroquinolone, and other oral antibiotics: a 10-year retrospective study of 1 million US senior Medicare beneficiaries

S Baik, J Lau, V Huser, CJ McDonald - BMJ open, 2020 - bmjopen.bmj.com
Objectives To assess the association of fluoroquinolone use with tendon ruptures compared
with no fluoroquinolone and that of the four most commonly prescribed non-fluoroquinolone …

Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions

ER Motrescu, S Blaise, N Etique, N Messaddeq… - Oncogene, 2008 - nature.com
The substrate of matrix metalloproteinase 11 (MMP11) remains unknown. We have recently
shown that MMP11 is a negative regulator of adipogenesis, able to reduce and even to …

Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle

ER Motrescu, MC Rio - 2008 - degruyter.com
This brief review focuses on the emerging role of matrix metalloproteinase 11 (MMP-11) in
cancer progression. It has recently been shown that MMP-11 is induced in adipose tissue by …

Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291

JG Naglich, M Jure-Kunkel, E Gupta, J Fargnoli… - Cancer research, 2001 - AACR
BMS-275291 is an po bioavailable, sulfhydryl-based matrix metalloproteinase (MMP)
inhibitor currently in clinical development for the treatment of cancer. This inhibitor was …

Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure− activity study

S Vassiliou, A Mucha, P Cuniasse… - Journal of medicinal …, 1999 - ACS Publications
Several phosphinic pseudo-tripeptides of general formula R-XaaΨ (PO2-CH2) Xaa '-Yaa '-
NH2 were synthesized and evaluated for their in vitro activities to inhibit stromelysin-3 …